Editorial: Mutant p53 in Cancer Progression and Personalized Therapeutic Treatments

Front Oncol. 2021 Aug 11:11:740578. doi: 10.3389/fonc.2021.740578. eCollection 2021.

Author

Oleg Timofeev¹

Affiliation

¹ Institute of Molecular Oncology, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.

No abstract available

Keywords: cancer stem cell; metabolic reprogramming; mutant p53; targeted therapy; tumor stroma.

Publication types

Editorial